War over drug-cost assistance traps sickest patients in the middle By: MarketWatch October 03, 2022 at 13:39 PM EDT Opaque health-plan provisions sharply increase costs for people with complex conditions Read More >> Related Stocks: AbbVie Astrazeneca Plc ADR Pfizer